Wedge Capital Management L L P Corcept Therapeutics Inc Transaction History

Wedge Capital Management L L P

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$10.41 - $14.66 $577,994 - $813,967	-55,523 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$9.78 - $12.76 $39,657 - $51,741	4,055 Added 7.88%	55,523 $619,000
Q1 2019 May 02, 2019	BUY	$10.03 - $15.71 $516,224 - $808,562	51,468 New	51,468 $604,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.43B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.